My watch list  


Combination of
Ipratropium Muscarinic antagonist
Salbutamol Short-acting β2-adrenergic agonist
CAS number  ?
ATC code  ?
PubChem  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes Inhalation

The combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ipratropium/salbutamol". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE